CIDRAP newsletters options
A study in The Lancet Infectious Diseases demonstrates that previous Omicron BA.1 infection was the most protective factor against BA.2 infection (associated with a risk reduction of 72%) and gave greater protection than primary infection with pre-Omicron SARS-CoV-2 (38%) or three doses of an mRNA vaccine in people with no previous infection (46%).
Biopharmaceutical company Spero Therapeutics announced today that it has entered into a licensing agreement with GSK for the antibiotic tebipenem pivoxil hydrobromide (HBr).
"We are only beginning to understand the toll of the pandemic on HCW well-being."
After a 5-week drop, global COVID-19 cases stabilized last week, though deaths continued to decline, the WHO says.
The COVID-19 pandemic dramatically worsened disparities in all-cause death rates for American Indian and Alaska Native (AIAN), Native Hawaiian, other Pacific Islander (NHOPI), and Black Americans and eroded mortality advantages for Asian and Hispanic groups, finds a study published yesterday in PNAS.
A new report from Scotland's national health service shows that three key healthcare-associated infections remained stable or declined from 2020 to 2021.
Healthcare workers in lower-paying roles, however, were more likely to face unemployment.
The outbreak includes 1 confirmed fatal case and 8 suspected infections in people who are receiving medical care.
Multiple factors may be keeping these vulnerable populations from obtaining and using antibiotics appropriately.
Boston public schools (BPS) yesterday announced the first monkeypox case in an "adult member of the BPS community," according to a letter sent to parents. The school district said the person was isolating at home, and the district was working to identify exposed individuals.
At a routine press briefing today, two White House officials fielded questions about President Joe Biden's recent off-the-cuff comment during a news program that the pandemic is over, while acknowledging that COVID is still a problem.
The comments prompted swift and sharp criticism among some public health experts.
"We think these principles can be applied to the next respiratory viral epidemic," a committee chair said of the SHEA statement.
One of the Florida infant's 4 caretakers reported high-risk activities before the baby contracted monkeypox.
Moderna's 2-strain booster triggered stronger antibody responses that its original booster did.
In its weekly flu update on Sep 16, the Centers for Disease Control and Prevention (CDC) reported two more variant H1N2 (H1N2v) infections, in Michigan and Wisconsin.
About 9 months after COVID-19 infection, 19% of nonhospitalized adult patients in a German cohort had fatigue, 26% had mild cognitive impairment ("brain fog"), and 1% had moderate cognitive dysfunction, according to a multicenter study.
The study, published late last week in EClinicalMedicine, also showed that the incidence and risk factors for fatigue and cognitive impairment differed by age-group.
Zero of 313 exposed healthcare workers got monkeypox, even though only 23% wore adequate protective equipment.
After 2 years, 12% had lingering symptoms and 8% had new-onset or worsening symptoms.
One in three unvaccinated COVID-19 survivors in a Spanish cohort had no detectable SARS-CoV-2 antibodies nearly 1 year after infection, according to a prospective study published today in BMC Medicine.
